Tan C, Luo X, Li S, Yi L, et al. Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis. Clin Rheumatol 2021 Aug 10. pii: 10.1007/s10067-021-05876.
PMID: 34373933